Abstract Details
|
Adam Dickey, MD, PhD
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Matthew C. Agan, MD (Wellstar Medical Group) | No disclosure on file |
| William P. Roche, MD (Neurology Associates, LLP) | No disclosure on file |
| Panayiotis Mitsias, MD (Henry Ford Hospital, Neurology) | The institution of Dr. Mitsias has received research support from European Union. |
| Michael R. Frankel, MD (Emory Univ School of Med/Dept of Neuro) | The institution of Dr. Frankel has received research support from Nico Corporation, Inc. |
| Jonathan Ratcliff | The institution of Dr. Ratcliff has received research support from Nico Corporation. The institution of Dr. Ratcliff has received research support from Sense . |
| No disclosure on file | |
| Raul G. Nogueira, MD (UPMC Stroke Institute) | Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus. |
| Diogo C. Haussen, MD | Dr. Haussen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stryker. Dr. Haussen has received stock or an ownership interest from Viz AI. |
| Ioannis Karakis, MD, FAAN (Emory University) | Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson. |